Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: A comparison with patients with PBC alone

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 9, 1998, Pages 897-901

  Akimoto, Sachiko ^a,b   Ishikawa, Osamu ^a   Takagi, Hitoshi ^a   Miyachi, Yoshiki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Anti centromere antibody; E1 of pyruvate dehydrogenase complex; Primary biliary cirrhosis; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; MITOCHONDRION ANTIBODY; PYRUVATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CENTROMERE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; ONSET AGE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SYNDROME CREST; SYSTEMIC SCLEROSIS;

EID: 0031780445     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00758.x     Document Type: Article

References (30)

1. Kaplan MM. Primary biliary cirrhosis. N. Engl. J. Med. 1987; 316: 521-8.
2. Powell FC, Schroeter AL, Dickson ER. Primary biliary cirrhosis and the CREST syndrome: A report of 22 cases. Quart. J. Med. 1987; 62: 75-82.
3. Murray-Lyon IM, Thompson RPH, Ansell ID, Williams R. Scleroderma and primary biliary cirrhosis. Br. Med. J. 1970; 3: 258-9.
4. Reynolds TB, Denison EK, Frankl HD, Lieberman FL, Peters RL. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and teleangiectasia. Am. J. Med. 1971; 50: 302-12.
5. Clarke AK, Galbraith RM, Hamilton EBD, Williams R. Rheumatic disorders in primary biliary cirrhosis. Ann. Rheum. Dis. 1978; 37: 42-7.
6. Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc. Natl Acad. Sci. USA 1980; 77: 1627-31.
7. Tan EM, Rodnan GP, Garcia I et al. Diversity of antinuclear antibodies in progressive systemic sclerosis: Anticentromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 1980; 23: 617-25.
8. Bernstein RM, Callender ME, Neuberger JM, Hughes GR, Williams R. Anticentromere antibody in primary biliary cirrhosis. Ann. Rheum. Dis. 1982; 41: 612-14.
9. Makinen D, Fritzler M, Davis P, Sherlock S. Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum. 1983; 26: 914-17.
10. Berg PA, Klein R, Lindenborn-Fotinos J, Klöppel W. ATPase-associated antigen (M2): Marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 1982; II: 1423-6.
11. Van de Water J, Fregeau D, Davis P et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J. Immunol. 1988; 141: 2321-4.
12. Klein R, Wiebel M, Engelhart S, Berg PA. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin. Exp. Immunol. 1993; 92: 308-16.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23: 581-90.
14. Maricq HR, Weinrich MC, Keil JE et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum. 1989; 32: 998-1006.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31: 315-24.
16. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271-7.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 1975; 292: 344-7.
18. Sasaki H, Inoue K, Higuchi K et al. Primary biliary cirrhosis in Japan: National survey by the subcommittee on autoimmune hepatitis. Gastroenterologia Japonica 1985; 20: 476-85.
19. Stanley CJ, Perham RN. Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem. J. 1980; 191: 147-54.
20. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl Acad. Sci. USA 1979; 76: 4350-4.
21. Yeaman SJ. The mammalian 2-oxoacid dehydrogenase: A complex family. Trends Biochem. Sci. 1986; 11: 293-6.
22. Surh CD, Roche TE, Danner DJ et al. Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex. Hepatology 1989; 10: 127-33.
23. Fregeau DR, Roche TE, Davis PA, Coppel R, Gershwin ME. Primary biliary cirrhosis: Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1α, a non-lipoic acid containing mitochondrial enzyme. J. Immunol 1990; 144: 1671-6.
24. Fujimoto M, Sato S, Ihn H, Kikuchi K, Tamaki K, Takehara K. Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1α antibody as a serologic indicator for development of primary biliary cirrhosis. Arthritis Rheum. 1995; 38: 985-9.
25. Bassendine MF, Fussey SPM, Mutimer DJ, James OFW, Yeaman SJ. Identification and characterization of four M2 mitochondrial autoantigens in primary biliary cirrhosis. Semin. Liver Dis. 1989; 9: 124-31.
26. Fussey SPM, Bassedine MF, Fittes D, Turner IB, James OFW, Yeaman SJ. The E1α and E1β subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis. Clin. Sci. 1989; 77: 365-8.
27. Fussey SPM, West SM, Lindsay JG et al. Clarification of the identity of the major M2 autoantigen in primary biliary cirrhosis. Clin. Sci. 1991; 80: 451-5.
28. Owen P, Kaback HR, Graeme-Cook KA. Identification of antigen 19/27 as dihydrolipogenase and its probable involvement in ubiquinone-mediated NADH-dependent transport phenomena in membrane vesicles of Escherichia coli. FEMS Microbiol. Lett. 1980; 7: 345-8.
29. Danson MJ, Conroy K, McQuattie A, Stevenson KJ. Dihydrolipoamide dehydrogenase from Trypasoma brucei. Characterization and cellular location. Biochem. J. 1987; 243: 661-5.
30. Danson MJ. Dihydrolipoamide dehydrogenase: a 'new' function for an old enzyme? Biochem. Soc. Trans. 1988; 16: 87-9.